🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 02262M407 (prev. 02262M308 )
- Market Cap
- Micro Cap
- IPO
- 6/15/2021 · $5.00/share
Business: Alzamend Neuro™, Inc., is a Delaware corporation with its corporate headquarters in Tampa, Florida with nexus in California. The mission of Alzamend Neuro™ is to help the Alzheimer’s community by supporting the full product development life cycle of treatment and cures for Alzheimer’s Disease (“AD”) driven by the belief that strong support of research is the foundation for true innovation.
Company Contact
- CEO
- Stephan Jackman
- CFO
- David J. Katzoff
- Headquarters
- 3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA 30326
- Phone
- 844-722-6303
- Investor Relations
- 844-722-6333 · Info@Alzamend.com